Vaccine shipping and cold chain requirements

Vaccine and medical syringe

Key takeaways

  • Vaccine shipping conditions depend on the exact product, formulation and presentation.

  • Refrigerated, frozen and ultra-cold ranges are not interchangeable, and mRNA vaccines do not share one universal range.

  • Qualified packaging must protect against both excessive heat and unintended freezing where relevant.

  • Hold questionable stock and seek an authorized assessment rather than automatically using or discarding it.

Vaccine shipping must maintain the conditions specified for the exact vaccine and presentation through delivery into appropriate storage. The vaccine cold chain can include refrigerated, frozen or ultra-cold handling, but a broad vaccine category does not establish the correct range for an individual shipment.

Before dispatch, verify the current manufacturer instructions, formulation, container type, expiry and any time limits after thawing or transfer. Then select the packaging, transport and receiving process to match.

Cold chain requirements start with the product label

The CDC Vaccine Storage and Handling Toolkit, July 2026 describes vaccine storage, transport and monitoring practices. Product-specific instructions remain essential because presentations and permitted conditions can differ.

The table shows common temperature-control categories. These are reference ranges, not permission to assign a vaccine to a category without checking its instructions.

Category

Common reference range

Shipment decision

Refrigerated

2–8°C

Prevent freezing as well as overheating for freeze-sensitive products

Frozen

Often -50 to -15°C in vaccine storage guidance

Verify the exact product range, permitted transport method and coolant

Ultra-cold

For some presentations, -90 to -60°C

Verify whether that presentation requires ultra-cold storage and any permitted transition

After thawing, preparation or first use

Product-specific temperature and time limits

Track the relevant clock and do not reset it after another transfer

Diluents and other components can have different instructions from the vaccine itself. Do not freeze a component simply because another item in the shipment requires frozen transport.

The mRNA vaccine cold chain is presentation-specific

The mRNA cold chain does not have one universal ultra-cold requirement. Formulations, vial presentations and prefilled syringes can have different storage and transport instructions, including restrictions on freezing or refreezing.

For example, the current FDA-hosted COMIRNATY package insert distinguishes presentations and their handling requirements. It should be checked for the exact product being moved rather than used to assign conditions to every mRNA vaccine.

When shipping vaccines after a permitted transfer to refrigerated conditions, document the transfer time and resulting use-by limit. The original expiry date does not automatically remain the only relevant deadline. A permitted storage interval should not be treated as an unrestricted shipping interval.

Select cold chain packaging for vaccines

Choose a packout supported for the product range, payload and anticipated route, including a justified delay allowance. Cooling too aggressively can damage freeze-sensitive vaccines. Conditioning and separation from coolant matter as much as the amount of insulation.

Use the package assembly instructions and the approved refrigerant configuration. Do not replace coolant, reduce insulation or add dry ice without assessing whether the resulting conditions remain suitable. Mercury's active and passive packaging guide explains the different operating dependencies.

For cold chain vaccine shipments that use dry ice, assess the coolant's dangerous goods requirements separately. Mercury's dry ice shipping guide covers that transport workflow.

Vaccine shipment condition monitoring

Use monitoring suited to the product and transport arrangement. Define the measurement accuracy, recording interval, probe location, start and stop points, and who reviews the data. Place the sensor according to the qualified packout and monitoring instructions so it reflects the relevant vaccine conditions.

CDC recommends appropriate temperature monitoring during transport, including a buffered probe placed with the vaccines in its relevant transport guidance. Program-specific rules, such as Vaccines for Children requirements, should be checked with the responsible immunization program. Do not turn one program's record-review schedule into a universal rule for all commercial vaccine distribution.

A real-time alert can support intervention, while a downloadable logger supports retrospective review. Both require a defined owner. A tracking scan alone does not establish that vaccine conditions were maintained.

Receive, inspect and escalate questionable stock

Arrange delivery when trained staff and appropriate storage are available. On arrival, verify the product, lot, quantity, package condition and relevant temperature evidence, then transfer the stock according to its instructions.

If the shipment may have experienced unacceptable conditions, identify and hold the affected stock under appropriate conditions and contact the responsible coordinator, manufacturer or immunization program. Do not use or discard it solely on appearance. Preserve the complete temperature history and handling information for an authorized assessment.

The detailed investigation belongs in Mercury's temperature excursion investigation guide. Here, the priority is to prevent affected stock from entering use before that decision is made.

Evaluate vaccine cold chain couriers against the route

Before selecting the transport arrangement, confirm:

  • The exact product conditions and permitted transport method.

  • Packout preparation, monitoring and delivery-window responsibilities.

  • Carrier acceptance and any border or coolant requirements.

  • Delay escalation, approved intervention and receiving access.

  • Availability of complete shipment and condition records.

A suitable service protects the specific presentation through its actual journey. That evidence is more useful than a general promise to keep all vaccines cold.

Share on Linkedin
Share on X
Share on Facebook